Search results for "CROHN DISEASE"

showing 10 items of 196 documents

Comment to “Management of cytomegalovirus infection in inflammatory bowel diseases”

2012

.

cytomegaloviruHepatologybusiness.industryGastroenterologyInflammatory Bowel DiseasesAntiviral AgentsInflammatory bowel diseaseCytomegalovirus infectionCrohn DiseaseCytomegalovirus InfectionsImmunologyHumansMedicineColitis Ulcerativecytomegalovirus; Inflammatory bowel diseasebusinessGanciclovircytomegalovirusImmunosuppressive AgentsDigestive and Liver Disease
researchProduct

Vulvar involvement in pediatric Crohn’s disease: a systematic review

2018

Purpose: The aim of the study is to report a systematic review (from 2000 to 2017) of all pediatric cases of vulvar Crohn’s disease (VCD) and to highlight the key-points for a correct diagnosis and management of this rare condition. Methods: An electronic search using the Pubmed/Medline, Scopus, EMBASE, Cochrane database and Google Scholar database was performed according to PRISMA guidelines. Results: Twenty pediatric studies and 22 cases of VCD were included for analysis. All the articles reported a single case, except two articles where two cases, respectively, are described. Clinical vulvar examination showed the following main manifestations: vulvar erythema (9/22 cases, 40.9%), vulv…

endocrine systemmedicine.medical_specialtyPediatric Crohn's diseaseVulvar edemaAdministration TopicalAdministration OralDiseasePerineumGastroenterologyVulvaPediatric Crohn’s disease030207 dermatology & venereal diseases03 medical and health sciencesPediatric Crohn’s disease0302 clinical medicineCrohn DiseaseObstetrics and gynaecologyMetronidazoleInternal medicineEdemaHumansMedicineVulvar diseaseChildbusiness.industryObstetrics and GynecologyGeneral MedicineDermatologyExtra-intestinal Crohn’s disease030220 oncology & carcinogenesisVulvar edemaFemaleVulvar DiseasesExtra-intestinal Crohn’s diseasebusinessExtra-intestinal Crohn’s disease; Pediatric Crohn’s disease; Vulvar disease; Vulvar edema; Obstetrics and Gynecology
researchProduct

Biologic therapies versus conventional therapies. A series of Crohn’s disease patients: “a pair-matched study”

2011

infliximab crohn disease
researchProduct

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study.

2017

Background: More than 50% of patients with Crohn's disease require intestinal resection at least once. Postoperative recurrence (POR) is almost uniform if prophylactic treatment is not started early. Endoscopic monitoring is generally advised. We studied the incidence and management of recurrence in patients who had undergone intestinal resection. Methods: Practicrohn was an observational retrospective study performed in 26 Spanish hospitals including patients aged >= 18 years who underwent Crohn's disease-related ileocolonic resection between January 2007 and December 2010. We recorded preventive treatments, the incidence of clinical recurrence in daily practice, and associated risk factor…

intestinal resectionAdultMaleReoperationmedicine.medical_specialtymedicine.medical_treatment03 medical and health sciencesYoung Adult0302 clinical medicineCrohn DiseaseInterquartile rangeRecurrenceRisk FactorsSecondary Preventionpostoperative recurrenceImmunology and AllergyMedicineHumansImmunologic FactorsPostoperative PeriodColectomyColectomyRetrospective StudiesCrohn's diseasemedicine.diagnostic_testbusiness.industryIncidence (epidemiology)IncidenceGastroenterologyRetrospective cohort studyEndoscopyBowel resectionmedicine.diseaseSurvival AnalysisEndoscopySurgeryCrohn's diseaseLogistic ModelsSpain030220 oncology & carcinogenesisPopulation study030211 gastroenterology & hepatologyFemaleprophylaxisbusinessFollow-Up StudiesInflammatory bowel diseases
researchProduct

Mesalazine for the treatment of inflammatory bowel disease

2013

Ulcerative colitis (UC) and Crohn's disease (CD) represent a chronic inflammatory condition of the bowel that often require lifelong medical therapy for the induction and maintenance of the remission. Mesalazine therapies are available both as oral delayed-release and sustained-release formulation, topical formulations and as prodrug.Available literature regarding mesalazine is extensively reviewed in this article, covering its mechanism of action, pharmaceutics and pharmacokinetics, clinical efficacy, safety and tolerability in different settings.Mesalazine has a well-established role in the management of UC. It is the treatment of choice in active and inactive mild-to-moderate UC combinin…

medicine.medical_specialtyColorectal cancerDiseaseGastroenterologyInflammatory bowel diseasechemistry.chemical_compoundCrohn DiseaseMesalazineInternal medicineSecondary PreventionmedicineHumansPharmacology (medical)Intestinal MucosaColitisMesalaminePharmacologyCrohn's diseasebusiness.industryAnti-Inflammatory Agents Non-SteroidalGeneral Medicinemedicine.diseaseUlcerative colitischemistryTolerabilityColitis UlcerativeColorectal NeoplasmsbusinessExpert Opinion on Pharmacotherapy
researchProduct

An update on medical management on Crohn's disease.

2014

The management of Crohn's disease (CD) is continuously evolving. New issues emerging from more recent studies could influence the decision-making process in clinical practice.The aim of this review article is to highlight critical issues on the management of CD, new evidence from clinical trials, long-term prospective studies and real life experience, beyond the current guidelines.The role of mucosal healing in clinical practice is uncertain, clinical remission remains the primary end point. The timing for the definition of steroid-resistant CD should be considered between 2 and 4 weeks. Early treatment strategy with immunomodulators is effective for inducing remission but no controlled dat…

medicine.medical_specialtyCombination therapyAzathioprineDiseasechemistry.chemical_compoundMesalazineAdjuvants ImmunologicCrohn DiseaseClinical endpointMedicineHumansPharmacology (medical)Prospective StudiesIntensive care medicinePharmacologyCrohn's diseaseBiological ProductsClinical Trials as Topicbusiness.industryTumor Necrosis Factor-alphaRemission InductionGeneral Medicinemedicine.diseaseReview articleSurgeryClinical trialchemistryPractice Guidelines as TopicDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drugExpert opinion on pharmacotherapy
researchProduct

Veränderungen im klinischen Bild und der chirurgischen Therapie bei Morbus Crohn Erfahrungen aus 10 Jahren

1998

Changes in clinical presentation of Crohn's disease (CD), patients' age at the time of disease manifestation and operation, general condition and duration of medical management were investigated in a retrospective study. 395 operations for CD were divided into consecutive groups and analysed. In an increasing number of cases patients presented with the "fibrostenotic type" rather than the "fistulizing type" of complaints. The duration of disease and of medical management increased. Patients in later groups were younger and in better general condition. We found a rise in frequency of patients with recurrent CD or prior abdominal surgery for other reasons. Primary surgery for CD increasingly …

medicine.medical_specialtyCrohn diseasebusiness.industryRetrospective cohort studyDiseaseResectionSurgerySurgical therapyEmergency surgerymedicineSurgeryPresentation (obstetrics)businessAbdominal surgeryDer Chirurg
researchProduct

Cytomegalovirus Pneumonia: A Possible Cause of Death in Patients With Crohn's Disease

2013

.

medicine.medical_specialtyCrohn's diseaseGastrointestinal agentCytomegalovirus pneumoniaHepatologyCrohn diseasebusiness.industryGastroenterologymedicine.diseaseCytomegalovirus Cytomegalovirus Infections ColitisGastroenterologyCytomegalovirus pneumonia Crohn’s diseaseAntibodies monoclonalInternal medicinemedicineIn patientbusinessCause of deathAmerican Journal of Gastroenterology
researchProduct

ATG16L1 contribution to Crohnʼs disease risk in Sicily

2011

medicine.medical_specialtyCrohn's diseaseSettore MED/09 - Medicina InternaPolymorphism Geneticbusiness.industryGastroenterologyAutophagy-Related Proteinsmedicine.diseaseGastroenterologyCrohn DiseaseRisk FactorsInternal medicinemedicineHumansImmunology and AllergyCarrier ProteinsbusinessCrohn's disease.genetics.ATG16L1SicilyATG16L1Inflammatory Bowel Diseases
researchProduct

Deficit of Interleukin-7 in Serum of Patients with Crohn's Disease

2013

medicine.medical_specialtyCrohn's diseasebusiness.industryInterleukin-7GastroenterologyInterleukinmedicine.diseaseGastroenterologyCrohn DiseaseInternal medicineCase-Control StudiesmedicineImmunology and AllergyHumansbusinessBiomarkers
researchProduct